[Iron as a cardiovascular risk factor. Its interaction with the classic risk factors]

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026

Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

European heart journal·2026

Related Experiment Videos

[Iron as a cardiovascular risk factor. Its interaction with the classic risk factors]

Related Concept Videos

Effects of biliopancreatic diversion on diurnal leptin, insulin and free fatty acid levels.

Critical assessment of the current guidelines for the management and treatment of morbidly obese patients.

[Insulin secretion and insulin sensitivity in relation to glucose tolerance in a group of subjects at a high risk for type 2 diabetes mellitus].

Study on growth hormone and insulin secretion in myotonic dystrophy.

[The importance of computerized axial tomography in the etiological diagnosis of Addison's disease].

[Pituitary apoplexy: analysis of endocrine function in 17 cases].

Temporal trends in motor neuron disease mortality in Spain (2000-2024): Population ageing versus generational risk factors.

Feasibility and characteristics of contrast-enhanced lung ultrasound in the diagnosis of pulmonary embolism in hospitalized patients.

Secukinumab in moderate to severe hidradenitis suppurativa: effectiveness and safety in real-world clinical practice.

Tularemia: a re-emerging zoonosis.

Complex regional pain syndrome and amputation.

Comparative efficacy and safety of rosuvastatin versus atorvastatin after acute ischemic stroke or transient ischemic attack: A systematic review and exploratory meta-analysis.

Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: The NOTION-4 Trial.

Effect of colchicine on C-reactive protein level following hospitalization for myocardial infarction: a meta-analysis of randomized, placebo-controlled trials.

Antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation: an individual patient data network meta-analysis.

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

Related Experiment Videos

[Iron as a cardiovascular risk factor. Its interaction with the classic risk factors]

Related Concept Videos

Related Articles